The Singapore LGBT encyclopaedia Wiki

The term variant of concern (VOC) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a category used when mutations in Receptor Binding Domain (RBD) substantially increase binding affinity (e.g., N501Y) in RBD-hACE2 complex (genetic data), while also being linked to rapid spread in human populations (epidemiological data).[1]

Before this, an emerging variant may have been labeled a "variant of interest".[2] During or after fuller assessment as a "variant of concern" the variant is typically assigned to a lineage in the PANGOLIN nomenclature system[3] and to clades in the Nextstrain[4] and GISAID[5] systems.

During the COVID-19 pandemic, the SARS-CoV-2 virus was observed to mutate, with certain combinations of specific point mutations proving to be more concerning than others.[6] This was principally for reasons of transmissibility and virulence, and also with regard to the possible emergence of escape mutations.

Criteria considered during COVID-19[]

Several national and international health organisations (e.g. Centers for Disease Control and Prevention (CDC) (US), Public Health England (PHE) and the COVID-19 Genomics UK Consortium for the UK, and the Canadian COVID Genomics Network (CanCOGeN)) use some or all of the following criteria to assess variants:[7][8]

  • Increased transmissibility
  • Increased morbidity
  • Increased mortality
  • Increased risk of “long COVID
  • Ability to evade detection by diagnostic tests
  • Decreased susceptibility to antiviral drugs (if and when such drugs are available)
  • Decreased susceptibility to neutralizing antibodies, either therapeutic (e.g., convalescent plasma or monoclonal antibodies) or in laboratory experiments
  • Ability to evade natural immunity (e.g., causing reinfections)
  • Ability to infect vaccinated individuals
  • Increased risk of particular conditions such as multisystem inflammatory syndrome or long-haul COVID.
  • Increased affinity for particular demographic or clinical groups, such as children or immunocompromised individuals.


Variants that appear to meet one or more of these criteria may be labeled "variants of interest" or "variants under investigation" ('VUI') pending verification and validation of these properties. Once validated, variants of interest /VUI may be renamed "variants of concern" by monitoring organizations, such as the CDC.[2][6][9] A related category is "variant of high consequence", used by the CDC if there is clear evidence that the effectiveness of prevention or intervention measures for a particular variant is substantially reduced.[10]



As of 12 May 2021, Canada was specifically tracking three Variants of concern, B.1.1.7, B.1.351, and P.1.[11]


As of 11 May 2021, the European Centre for Disease Prevention and Control had declared interest in four Variants of concern, B.1.1.7, B.1.1.7+E484K, B.1.351, and P.1. They named a further nine Variants of interest (VOI): B.1.525, B.1.427/B.1.429, P.3, B.1.616, B.1.617.1, B.1.617.2,B.1.617.3, B.1.620, and B.1.621, while 17 more were described as 'Variants under monitoring'.[12]

United Kingdom[]

As of 5 March 2021, the United Kingdom has eight variants on its 'watch list', 4 with 'VOC' status and 4 rated as 'VUI', with PHE adding the fourth VUI after 16 people had tested positive for it at dates beginning with 15 February.[13] The latest variant is VUI-21FEB-04 (Lineage B.1.1.318), and was designated a VUI on 24 February. Other VUIs are P.2, VUI-21FEB-01 (A.23.1 with E484K), and B.1.525, while VOCs are Lineage B.1.1.7, Lineage B.1.351, Lineage P.1, and Lineage B.1.1.7.[14][15]

Note that in March 2021, PHE changed their naming convention to use the format [YY][MMM]-[NN], where the month is written out using a three-letter code.[16]

United States[]

The CDC maintains a list of variants of concern. As of May 2021, they are tracking B.1.1.7, B.1.351, the related variants B.1.427 and B.1.429, and P.1.[17]

World Health Organization[]

The WHO maintains a list of variants of global concern.[18]


  1. Template:Cite journal
  2. 2.0 2.1 Template:Cite web
  3. Template:Cite journal
  4. Template:Cite web
  5. Template:Cite web
  6. 6.0 6.1 Template:Cite web
  7. Template:Cite web
  8. Template:Cite web Template:PD-notice
  9. Investigation of SARS-CoV-2 variants of concern in EnglandTechnical briefing 6 13 February 2021 (See section: Nomenclature of variants in the UK, P.3), accessed 27 February 2021
  10. Template:Cite web
  11. COVID-19 daily epidemiology update 12 May 2021 accessed 13 May 2021
  12. SARS-CoV-2 variants of concern as of 11 May 2021 11 May 2021 accessed 13 May 2021
  13. Covid-19: Another new variant added to UK watch list Michelle Roberts, 4 March 2021, accessed 5 March 2021
  14. Variants of concern or under investigation: data up to 3 March 2021 4 March 2021, accessed 5 March 2021
  15. Latest update: New Variant Under Investigation designated in the UK 4 March 2021, accessed 5 March 2021
  16. Template:Cite web
  17. Template:Cite web
  18. Template:Cite web